NCT01351090View on ClinicalTrials.gov

Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine (IN) for Postoperative Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2007

Conditions
Postoperative Pain
Interventions
DRUG

Ketorolac tromethamine

10 mg Intranasal (2 x 100 uL of a 5% solution)

DRUG

Ketorolac tromethamine

30 mg Intranasal (2 x 100 uL of a 15% solution)

DRUG

Placebo

Intranasal

Trial Locations (1)

Unknown

Waikato Clinical Research, Hamilton

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY